Clive Meanwell

CIK: 0001204787

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

GUTS

FRACTYL HEALTH, INC.

Director

MTSR

Metsera, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

GUTS
FRACTYL HEALTH, INC.
Jun 10, 2026
Award(A)
Stock Option
Direct
22.5K shares-
MTSR
Metsera, Inc.
Nov 13, 2025
Disposition(D)
Direct
5.4K shares-
MTSR
Metsera, Inc.
Nov 13, 2025
Disposition(D)
Indirect
12.8M shares-
MTSR
Metsera, Inc.
Nov 13, 2025
Award(A)
Restricted Stock Unit
Direct
5.4K shares-
GUTS
FRACTYL HEALTH, INC.
Jun 11, 2025
Award(A)
Stock Option
Direct
22.5K shares-
MTSR
Metsera, Inc.
May 20, 2025
Award(A)
Stock Option (Right to Buy)
Direct
32.3K shares-

		Type	Shares	Price		Ownership
Jun 10, 2026	GUTS FRACTYL HEALTH, INC.	Award(A) Stock Option	22,500	-	-	Direct
Nov 13, 2025	MTSR Metsera, Inc.	Disposition(D)	5,375	-	-	Direct
Nov 13, 2025	MTSR Metsera, Inc.	Disposition(D)	12,767,462	-	-	Indirect
Nov 13, 2025	MTSR Metsera, Inc.	Award(A) Restricted Stock Unit	5,375	-	-	Direct
Jun 11, 2025	GUTS FRACTYL HEALTH, INC.	Award(A) Stock Option	22,500	-	-	Direct
May 20, 2025	MTSR Metsera, Inc.	Award(A) Stock Option (Right to Buy)	32,250	-	-	Direct

1-6 of 6 transactions

About MEANWELL CLIVE

MEANWELL CLIVE (SEC CIK 0001204787) files insider reports with the SEC as Director of FRACTYL HEALTH, INC. (GUTS) and Executive Chairman of Metsera, Inc. (MTSR).

Signal8 holds 5 ownership filings by MEANWELL CLIVE (1 Form 3, 4 Form 4), filed between Jan 30, 2025 and Jun 11, 2026. Those filings report 6 transactions, from May 20, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MEANWELL CLIVE's filings is in BURLINGTON, MA.

Recent filings by MEANWELL CLIVE

Jun 10, 2026: Grant or award of GUTS derivative securities (Form 4, code A).
Nov 13, 2025: Disposition to issuer transactions of MTSR shares (2 lines, Form 4, code D).
Nov 13, 2025: Grant or award of MTSR derivative securities (Form 4, code A).
Jun 11, 2025: Grant or award of GUTS derivative securities (Form 4, code A).
May 20, 2025: Grant or award of MTSR derivative securities (Form 4, code A).

Other insiders filing for FRACTYL HEALTH, INC. (GUTS)

BRADLEY WILLIAM, Director
Royan Ajay, Director
Conaway Samuel, Director
Thompson Christopher Charles, Director
Elia Marc, Director
Barnes Kelly Ann, Director

How to read Form 4 transaction codes